Background: Gastric bypass and duodenal switch are currently performed bariatric surgical procedures. Uncontrolled studies suggest that duodenal switch induces greater weight loss than gastric bypass.
T
he risk for obesity-related comorbid conditions increases progressively with weight (1, 2) , and body mass index (BMI) is associated with increased mortality, primarily from cardiovascular disease and several types of cancer (3) (4) (5) . Weight loss can reduce the risk for health complications (6, 7) . Although severely obese persons may benefit from lifestyle intervention in the short term (8) , few data on the long-term efficacy of nonsurgical interventions are available (9, 10) . Recent studies have demonstrated that bariatric surgery can induce a sustained weight loss that is associated with favorable effects on obesity-related comorbid conditions (11) , cancer incidence (12) , quality of life (13) , and death (14) .
Recent survey data from the United States indicate that at least 5% of the population meets the criteria for bariatric surgery (15) . The prevalence of severe obesity has increased relatively more than that of overweight and moderate obesity (16) . About one third of patients who have bariatric surgery in the United States has a BMI of more than 50 kg/m 2 (called superobesity) (17, 18) . After Roux-en-Y gastric bypass surgery and achieving peak weight loss, these patients often still have a BMI above 35 kg/m 2 (19) . Evidence from nonrandomized studies suggests that biliopancreatic diversion with duodenal switch may lead to greater weight loss than gastric bypass (20, 21) . To our knowledge, these procedures have not been compared in a randomized clinical trial. We therefore conducted a randomized trial of gastric bypass and duodenal switch in superobese patients to address the hypothesis that greater weight loss after duodenal switch is associated with improvements in cardiovascular risk factors and health-related quality of life. Previously published 1-year follow-up data from the same trial demonstrated a greater weight loss after duodenal switch (22, 23) , and the present study contributes longer-term follow-up and supplementary data. We sought to compare gastric bypass with 1-stage duodenal switch surgery. We did not include patients with a BMI greater than 60 kg/m 2 ; in such patients, duodenal switch is often performed in 2 stages to reduce surgery-related morbidity (24) .
METHODS

Design
The study was an unblinded, prospective, randomized clinical trial. Participants were recruited from referrals for treatment of morbid obesity between March 2006 and August 2007. Two-year follow-up was completed in November 2009. Signed, informed consent was obtained from all participants. The trial protocol was approved by appropriate local ethics committees.
Setting and Participants
Recruitment, interventions, and data collection were performed at Oslo University Hospital Aker, Oslo, Norway, and Sahlgrenska University Hospital, Gothenburg, Sweden.
Participants were eligible for inclusion if they had a BMI of 50 to 60 kg/m 2 , were aged 20 to 50 years, and had not sustained previous weight loss. Exclusion criteria were a history of major abdominal or bariatric surgery, disabling cardiopulmonary diseases, cancer, longterm treatment with oral corticosteroids, and conditions associated with poor adherence. Before inclusion, participants were informed about the expected outcomes of both operations. The baseline assessment included recording of medical history and current medications and a physical examination. Blood samples were obtained after an overnight fast.
Randomization and Interventions
Randomization was computer-derived at Sahlgrenska University Hospital by using LabView software, version 7.1 (National Instruments, Austin, Texas), with stratification according to study center, sex, age (Ͻ35 years or Ն35 years), and BMI (Ͻ55 kg/m 2 or Ն55 kg/m 2 ) by using the minimization method. Blocking was not used. Participants and surgeons were masked to treatment allocation until 1 week before surgery.
Participants followed a low-calorie diet (1000 kcal/d) for 3 weeks before surgery. Both operations were performed at both study centers by using standardized laparoscopic techniques (Figure 1) (22, 25) . In gastric bypass, the stomach was divided proximally to create a pouch of 25 mL and a gastric remnant. The jejunum was measured 50 cm from the ligament of Treitz and anastomosed to the pouch with the linear stapling technique. To create the alimentary limb, the jejunum was measured 150 cm distally from the gastrojejunal anastomosis and anastomosed to the 50-cm biliopancreatic limb. The small bowel was then transected between the 2 anastomoses to create a Roux-en-Y configuration with a long common channel, allowing food from the alimentary limb to be mixed with bile and pancreatic juices transported in the biliopancreatic limb. Duodenal switch consisted of longitudinal ("sleeve") gastrectomy along a nasogastric tube of 30 to 32 Fr. The small bowel was measured from the cecum to create a common channel of 100 cm and an alimentary limb of 200 cm. The procedure then involved a hand-sewn anastomosis between the duodenum and the ileum, an anastomosis between the biliopancreatic limb and the ileum, and transection of the bowel between the anastomoses. Mesenteric defects were not closed in either procedure. Participants consumed a liquid diet for the first week after surgery and a semiliquid diet for 1 week, then gradually returned to normal food intake.
Outcomes and Follow-up
The primary end point of the study was the change in BMI from baseline until 2 years after surgery. Secondary end points included changes in anthropometric measures, cardiovascular risk factors, health-related quality of life, body composition, vitamin concentrations, and adverse events. Weight was measured with participants wearing
Context
Two types of bariatric surgery are commonly used to treat severe obesity: gastric bypass and duodenal switch. Few controlled clinical trials of these procedures have been reported.
Contribution
Patients with a body mass index between 50 and 60 kg/m 2 were randomly assigned to undergo gastric bypass or duodenal switch. After 2 years, duodenal switch resulted in significantly greater reduction in body mass index than gastric bypass but was more commonly associated with adverse events. Dietary factors, quality of life, and cardiovascular markers varied with each procedure.
Caution
The effect of surgical experience on outcomes was not assessed.
Implication
Patients benefited from both types of bariatric surgery. The choice of procedure should be individualized.
-The Editors
Original Research Gastric Bypass and Duodenal Switch in Extreme Obesity light clothing and no shoes, with 1 kg subtracted to account for clothing. Weight change was reported as the reduction in BMI units (kg/m 2 ), total weight loss in kilograms, and percentage of body weight loss. In addition, the number of participants who had a BMI of 40 kg/m 2 or higher at 2 years after surgery was evaluated. Waist circumference was measured halfway between the caudal point of the costal arch and the iliac crest (26). Hip circumference was measured at the level of the femoral great trochanters. With the participant in the supine position, sagittal abdominal diameter was measured as the distance from the back to the highest point of the abdomen during normal expiration, as a proxy for visceral adipose tissue mass (27) .
Cardiovascular risk factors were evaluated by changes in fasting lipid concentrations (total cholesterol, highdensity lipoprotein [HDL] cholesterol, low-density lipoprotein [LDL] cholesterol, and triglycerides), glucose, insulin, and C-reactive protein and changes in blood pressure. Blood pressure was measured 3 times with an appropriately sized cuff after the participant had rested for 5 minutes, and the last 2 measurements were averaged. Comorbid conditions were diagnosed on the basis of referrals and clinical assessment. We previously reported methods for measuring vitamin concentrations and the participants' vitamin levels and dietary supplement intakes within 1 year after surgery (23, 28) . We now report vitamin concentrations until 2 years after surgery.
Generic health-related quality of life was assessed by using validated Norwegian and Swedish versions of the Short Form-36 Health Survey (SF-36) (4-week recall, version 2.0). This self-administered questionnaire consists of 8 domains, of which 4 reflect physical health and 4 reflect mental health. A score was calculated for each domain on a scale from 0 (worst possible health state) to 100 (best possible health state) (29) .
Body composition was evaluated by changes in fat mass and fat-free mass, as measured by bioelectrical impedance analysis in Norwegian participants (n ϭ 30; 2 participants exceeded the 200-kg weight capacity of the apparatus at baseline) by using the BC-418 (Tanita, Tokyo, Japan). In Swedish participants (n ϭ 30), total body potassium was estimated as a proxy for fat-free mass by measuring the amount of radioactive K-40 in a whole-body counter (Nuclear Enterprises, Edinburgh, United Kingdom) at the Department of Radiation Physics at Sahlgrenska University Hospital. The ratio of total body potassium to fat-free mass was set at 64.8 mmol/kg for men and 59.6 mmol/kg for women (30). The percentage of weight lost as fat-free mass ([⌬fat-free mass/ ⌬body weight] ϫ 100%) was calculated after both body composition studies.
At each postsurgery visit, participants were asked open-ended questions about the occurrence of any adverse events, including readmissions, and diagnostic or therapeutic procedures. We report the overall numbers of adverse events and events occurring more than 30 days after surgery. Thirty-day outcomes have been reported before (22) . All participants were prescribed daily supplements of multivitamins, 100 mg of iron sulfate, 1000 mg of calcium carbonate, and 20 mcg of vitamin D 3 . In addition, participants in the gastric bypass group received a vitamin B 12 substitute. Ursodeoxycholic acid was prescribed for 6 months, except in participants who had had cholecystectomy. Participants were seen by a dietitian and surgeon at inclusion and at 6 weeks, 6 months, 1 year, and 2 years after surgery. The dietitian visits included a dietary recall and evaluation of nutritional status and adherence to vitamin supplementation. Participants received top-up supplementation according to predefined cutoff levels of vitamin concentrations (23) .
Statistical Analysis
To estimate sample size, we performed a retrospective analysis of superobese patients who had undergone gastric bypass (n ϭ 19) or duodenal switch (n ϭ 13) at Sahlgrenska University Hospital. These patients had mean reductions in BMI of 18.0 kg/m 2 (SD, 6.7) and 24.9 kg/m 2 (SD, 5.0) after a mean follow-up of 34 and 31 months, respectively. Applying these data, we calculated that a total of 26 study participants would give 80% power to detect a significant (P Ͻ 0.050) difference between the groups. To allow for possible dropouts and add power for analysis of secondary outcomes, we decided to enroll 60 participants. Sample size was calculated in SamplePower 2.0 (SPSS, Chicago, Illinois). Linear mixed models were fitted to all outcome variables to account for the repeated measures by patient. Competing models were compared by using the Akaike information criterion and the Bayesian information criterion. We modeled time by using a piecewise linear spline with a knot at 12 months. Two variables (glucose and insulin) had a knot at 6 months instead of 12 months, and 2 variables (systolic and diastolic blood pressures) were modeled with only 1 slope. Time and time-by-treatment interaction were fixed effects in all models. All models included a random intercept. For some variables, models also included fixed effects for treatment and site and random slopes by patient.
We compared binomial proportions between treatment groups with the Pearson chi-square test and the Suissa-Shuster exact unconditional test, depending on whether all expected counts were above 5 (31) .
Linear mixed model analyses were performed with Stata, version 11.1 (StataCorp, College Station, Texas), and categorical analyses were performed with StatXact 9 (Cytel, Cambridge, Massachusetts). All P values are 2-tailed.
Role of the Funding Source
The trial was supported by the South-Eastern Norway Regional Health Authority. The funding source had no role in the design of the study; collection, analysis, and interpretation of the data; or drafting of the manuscript. Figure 2 shows the participant flow through the study. One participant withdrew after randomization but before being informed about the allocated intervention. Two participants in the duodenal switch group were lost to followup. Baseline characteristics did not significantly differ between groups ( Table 1) .
RESULTS
Weight Loss
After 2 years, the reduction in BMI was 17 (Figure 3 and Table 2 ). The corresponding weight loss was 50.6 kg (CI, 45.4 to 55.8 kg) after gastric bypass and 73.5 kg (CI, 68.1 to 79.0 kg) after duodenal switch (mean between-group difference, 23.0 kg [CI, 16.2 to 29.7 kg]; P Ͻ 0.001). Mean percentage of body weight loss was 31.2% (CI, 29.2% to 33.2%) after gastric bypass and 44.8% (CI, 42.8% to 46.8%) after duodenal switch. Two years after surgery, 8 of 31 participants (26%) in the gastric bypass group and 0 of 27 in the duodenal switch group had a BMI of 40 kg/m 2 or higher (P ϭ 0.006).
Anthropometric Measures and Body Composition
Both procedures were associated with significant reductions in waist circumference, hip circumference, and sagittal diameter at 2 years ( Table 2) . Reductions in all of these measures were significantly greater in the duodenal switch group.
Fat mass and fat-free mass were significantly reduced in both groups, as measured by bioelectrical impedance analysis (Appendix Table 1 , available at www.annals.org). Participants in the duodenal switch group lost significantly more fat mass and fat-free mass than those in the gastric bypass group. However, the mean percentage of weight lost as fat-free mass did not differ between groups (23.6% [CI, 21.2% to 25.9%] for gastric bypass and 24.6% [CI, 21.9% to 27.2%] for duodenal switch; mean between-group difference, 1.03 percentage points [CI, Ϫ2.36 to 4.42 percentage points]; P ϭ 0.54). Total body potassium measurements showed a greater reduction of fat-free mass after duodenal switch (Appendix Table  1 ). Total body potassium measurements also showed that the percentage of weight lost as fat-free mass did not significantly differ between groups (data not shown).
Markers of Cardiovascular Risk
Two years after surgery, total cholesterol concentration decreased by 0. Table 2 ). Mean systolic and diastolic blood pressures, fasting levels of glucose and insulin, and mean levels of C-reactive protein were all significantly reduced in both study groups with no between-group differences in the changes at 2 years ( Table 2 and Appendix Figure 1 , available at www.annals.org).
Participants at Sahlgrenska University Hospital had significantly greater reductions in hip circumference and blood pressure than those at Oslo University Hospital Aker. Changes in any other outcome variable did not significantly differ by hospital (data not shown). At study entry, 14 participants used antihypertensive drugs, whereas 2 used such drugs at 2 years. Similarly, 4 participants used oral hypoglycemic drugs and 2 used insulin before surgery, whereas 1 received insulin after surgery. Two participants received lipid-lowering therapy with statins at inclusion and none at 2-year follow-up.
Vitamin Concentrations
At 2-year follow-up, the duodenal switch group had lower mean concentrations of vitamin A and 25- BMI ϭ body mass index.
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Gastric Bypass and Duodenal Switch in Extreme Obesity www.annals.orghydroxyvitamin D than did the gastric bypass group (Appendix Table 2 , available at www.annals.org). Participants in the gastric bypass group received additional cobalamine supplements and had higher vitamin B 12 concentrations during follow-up. Other vitamins (vitamin B 6 , folate, vitamin C, and vitamin E adjusted for serum lipids) either were stable or increased at 2 years compared with baseline.
Health-Related Quality of Life
One participant in each group did not complete SF-36 forms after surgery and were excluded from analysis. After 2 years, 7 of 8 subscores significantly improved in gastric bypass participants (Appendix Figure 2 and Appendix Table 3, available at www.annals.org). In the duodenal switch group, 5 of 8 subscores significantly improved after 2 years. Bodily pain was the only domain in which improvements differed between groups, with a mean 20.2-point (CI, 6.71 to 33.7 points) greater improvement in the gastric bypass group (P ϭ 0.003).
Adverse Events
Overall, significantly more participants in the duodenal switch group had adverse events occurring from surgery and up until 2 years: 10 of 31 (32%) after gastric bypass compared with 18 of 29 (62%) after duodenal switch (P ϭ 0.021). Long-term (Ͼ30-day) adverse events occurred in 9 participants (29%) after gastric bypass (1 to 2 events per participant) and in 12 participants (41%) after duodenal switch (1 to 6 events per participant) (P ϭ 0.32) ( Table 3 ).
In the gastric bypass group, 6 participants had consultations for vomiting, abdominal pain, or diarrhea, of whom 1 had laparoscopy and 2 had upper endoscopies (all negative). Three participants developed symptomatic cholelithiasis and 1 had cholecystectomy. One participant had internal herniation requiring laparoscopic small-bowel reduction. Another was treated with antibiotics for bacterial enterocolitis. One participant was hospitalized for psychiatric disease.
In the duodenal switch group, 1 participant without excessive alcohol consumption developed acute hepatic failure (liver biopsy revealed steatohepatitis with fibrosis and cirrhosis), pneumonia, and protein-calorie malnutrition after laparoscopic surgery for bile duct stones (32) . Liver function improved from Child-Pugh score class C to A after nutritional support and management of liver failure. Two other participants required parenteral nu- 
Months After Surgery
Estimated postsurgery values are expected means from the linear mixedeffects models. Error bars indicate 95% CIs. P Ͻ 0.001 for betweengroup changes. BMI ϭ body mass index. BIA ϭ bioelectrical impedance analysis; BMI ϭ body mass index; BP ϭ blood pressure; CRP ϭ C-reactive protein; HDL ϭ high-density lipoprotein; LDL ϭ low-density lipoprotein; TBK ϭ total body potassium measurement. * Defined as a history of type 2 diabetes, a fasting plasma glucose concentration Ն7.0 mmol/L (Ն126 mg/dL), or both. In addition, 1 participant in the gastric bypass group had type 1 diabetes. † Data in Norwegian participants only (13 in the gastric bypass group and 15 in the duodenal switch group). ‡ Data in Swedish participants only (14 in the gastric bypass group and 14 in the duodenal switch group). § 1 participant in each group used insulin; they were excluded from the analysis. 6 missing values in each group at baseline.
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trition and a protein-enriched diet for malnutrition. Two participants had low serum concentrations of vitamin A and night blindness revealed by dark adaptometry, which resolved after adequate supplementation of vitamin A. One of these participants was later hospitalized for traumatic subarachnoid hemorrhage and Haemophilus influenzae meningitis, which was complicated by gangrene of fingers and toes that required partial amputations. One participant with iron deficiency received iron infusions. Laparotomy was performed in 3 participants because of peritonitis, inflammation of the transverse mesocolon, and small-bowel obstruction after an intra-abdominal abscess. The latter participant subsequently had another laparotomy for small-bowel obstruction. Laparoscopic cholecystectomy was performed in 1 participant. Four participants had upper endoscopies performed because of vomiting or abdominal pain (1 had a prepyloric ulcer with Helicobacter pylori infection). One participant experienced recurrent severe diarrhea that was managed with metronidazole, 1 participant developed urolithiasis, and 1 participant had a traumatic humerus fracture after a car accident.
DISCUSSION
In this randomized trial comparing duodenal switch with another bariatric surgical procedure, which we believe to be the first to do so, we show that duodenal switch 
Months After Surgery
Estimated postsurgery values are expected means from the linear mixed-effects models. Error bars indicate 95% CIs. To convert cholesterol values to mg/dL, divide by 0.0259. To convert triglyceride values to mg/dL, divide by 0.0113. HDL ϭ high-density lipoprotein; LDL ϭ low-density lipoprotein. * P Ͻ 0.001 for between-group changes. † P ϭ 0.78 for between-group changes.
Original Research Gastric Bypass and Duodenal Switch in Extreme Obesity induced a significantly and substantially greater weight loss than gastric bypass in superobese patients. Two years after surgery, 26% of participants who had gastric bypass still had a BMI more than 40 kg/m 2 compared with no participants after duodenal switch. These weight-loss data extend our previously published findings after shorter-term follow-up (22, 23) and those of uncontrolled studies conducted by others (20, 33) , which have been limited by the inherent bias in treatment allocation.
Bariatric surgery is associated with long-term weight loss and decreased overall mortality (14) . However, whether a dose-response relationship exists between the magnitude of weight loss after surgery and reduction in total or cardiovascular mortality is unknown. An important finding in our study was that despite a large difference in weight loss, both procedures induced substantial and, for most variables studied, similar improvements in markers of risk for cardiovascular disease. For blood lipids, we found significantly greater reductions in total and LDL cholesterol concentrations after duodenal switch, extending the shorter-term changes reported previously (23) . Other investigators have found a reduction in cardiovascular mortality in patients with hyperlipidemia and previous myocardial infarction who were randomly assigned to undergo partial ileal bypass (which is no longer done) compared with conservative treatment (34) .
Previous studies have shown beneficial effects of both gastric bypass and duodenal switch on cardiovascular risk factors and reduced mortality from heart disease after gastric bypass (21, (35) (36) (37) . Our finding of a 0.53-mmol/L (20.5-mg/dL) greater reduction in LDL cholesterol concentration after duodenal switch could mean that patients having this procedure have a greater reduction in longterm cardiovascular risk. In a meta-analysis of more than 90 000 participants in cholesterol-lowering trials, a 1-mmol/L (38.6-mg/dL) reduction in LDL cholesterol concentration translated into a 12% reduction in total mortality and a 19% reduction in coronary mortality over 5 years (38) . The reduction in LDL cholesterol may be explained by both weight loss and procedure-specific effects. A decreased absorption of cholesterol has been demonstrated after gastric bypass (39) . After duodenal switch, mixing of food with pancreatic enzymes and bile acids is more delayed, which may lead to more pronounced malabsorption of fat than with gastric bypass (40) .
The available evidence suggests that duodenal switch is associated with higher rates of resolution of hypertension, diabetes, and dyslipidemia, including in superobese patients (11, 41) . Although we observed some evidence of lower blood pressures and lower fasting serum glucose levels after duodenal switch than after gastric bypass, these differences were not statistically significant.
Patients who had duodenal switch had significantly lower levels of vitamin A and 25-hydroxyvitamin D than did patients who had gastric bypass. Additional supplementation of these fat-soluble vitamins in patients having duodenal switch has been proposed (21) . After gastric bypass, concentrations of vitamins were stable or increased. This indicates that the dietary supplementation regimen described in our trial may be adequate after gastric bypass surgery (23) , as also shown in a study of vitamin status after gastric bypass in a less obese cohort taking similar supplements (42) .
The substantially greater weight loss after duodenal switch was not associated with significantly greater improvements in health-related quality of life. The higher overall morbidity after duodenal switch may have had a negative effect on these participants' quality of life, although our study did not have statistical power to formally address this. The SF-36 subscores 2 years after duodenal switch are similar to those reported by other studies (43) . Weight regain in the long term after bariatric surgery is associated with deteriorations in health-related quality of life (13) . This suggests that if longer-term maintenance of weight loss differs between gastric bypass and duodenal switch, this may also influence quality of life.
Meta-analyses of current bariatric procedures suggest that duodenal switch is associated with the largest weight § Small-bowel obstruction due to internal herniation. All had cholecystolithiasis, except for 1 participant in the duodenal switch group who had common bile duct stones.
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Gastric Bypass and Duodenal Switch in Extreme Obesity www.annals.orgloss and greatest improvements of obesity-related comorbid conditions (11) . This operation is, however, difficult to perform by laparoscopy and has been associated with a higher mortality rate than laparoscopic gastric bypass (44) . Although some series have reported low morbidity rates after bariatric surgery in superobese patients (45, 46) , others have identified very high BMI as a risk factor for surgical complications (17) . Because duodenal switch is often reserved for patients with a BMI greater than 50 kg/m 2 , balancing the health benefits and safety of this operation to those of other procedures is important. Data from our study suggest that superobese patients opting for gastric bypass should be informed that they are likely to experience clinically important health benefits even though they may expect to still be severely obese after surgery. In contrast, duodenal switch provides greater weight loss and greater improvements in total and LDL cholesterol concentrations but at a potentially greater risk. Patients should also be informed that health-related quality of life seems to be relatively similar after both surgeries.
We suggest that duodenal switch surgery be restricted to well-informed superobese patients who are likely to adhere to clinical follow-up. Furthermore, we recommend more closely monitoring patients after duodenal switch than after gastric bypass because of the greater risk for micronutrient deficiencies after duodenal switch. In women of fertile age, malabsorptive procedures, such as duodenal switch, may be associated with an increased risk for pregnancy-related nutritional deficiencies and adverse neonatal outcomes (47, 48) . In future studies, the potential benefits of performing the duodenal switch as a 2-stage procedure need to be clarified (49) .
Strengths of our study include the prospective, randomized design and a high rate of completion. Our study also has several limitations. The study sample was predominantly female, which is common in studies of bariatric surgery. The study did not include participants older than 50 years, which may help explain why relatively few participants had type 2 diabetes. The results are limited by the small study size and the 2-year follow-up. Surgeons and the multidisciplinary treatment teams at both study centers had accumulated more clinical experience with gastric bypass than with duodenal switch, which may influence operating times and morbidity rates (22) . Although all known adverse events were recorded, we did not use a formal classification system for surgical complications. The findings may be generalizable only according to the surgical techniques used, such as the lengths of the intestinal limbs. Evaluation of body composition by bioelectrical impedance analysis may be useful for group comparisons but has not been thoroughly validated in obese persons (50). Finally, the study setting should be considered when interpreting the data; for example, most of the participants were of white ethnic origin (51) .
In summary, both gastric bypass and duodenal switch induced significant and durable weight loss in superobese patients. Weight loss and reductions of total and LDL cholesterol concentrations were greater after duodenal switch, and HDL cholesterol concentration increased after both procedures. Duodenal switch was also associated with lower concentrations of vitamin A and 25-hydroxyvitamin D and more adverse events during the 2-year follow-up. Both interventions were associated with significant improvements in other cardiovascular risk factors and health-related quality of life.
From Oslo University Hospital Aker and University of Oslo, Oslo, Norway, and Sahlgrenska University Hospital, Gothenburg, Sweden. 
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